Novel chimeric peptide with enhanced cell specificity and anti-inflammatory activity

作者：Kim Young Min; Kim Nam Hong; Lee Jong Wan; Jang Jin Sun; Park Yung Hoon; Park Seong Cheol; Jang Mi Kyeong^*

来源：Biochemical and Biophysical Research Communications, 2015, 463(3): 322-328.

DOI：10.1016/j.bbrc.2015.05.063

• Antimicrobial peptide
• Hybrid peptide
• Anti-inflammatory activity
• Drug-resistant bacteria
• Lipopolysaccharide

An antimicrobial peptide (AMP), Hn-Mc, was designed by combining the N-terminus of HPA3NT3 and the C-terminus of melittin. This chimeric AMP exhibited potent antibacterial activity with low minimal inhibitory concentrations (MICs), ranging from 1 to 2 mu M against four drug-susceptible bacteria and ten drug-resistant bacteria. Moreover, the hemolysis and cytotoxicity was reduced significantly compared to those of the parent peptides, highlighting its high cell selectivity. The morphological changes in the giant unilamellar vesicles and bacterial cell surfaces caused by the Hn-Mc peptide suggested that it killed the microbial cells by damaging the membrane envelope. An in vivo study also demonstrated the antibacterial activity of the Hn-Mc peptide in a mouse model infected with drug-resistant bacteria. In addition, the chimeric peptide inhibited the expression of lipopolysaccharide (LPS)-induced cytokines in RAW 264.7 cells by preventing the interaction between LPS and Toll-like receptors. These results suggest that this chimeric peptide is an antimicrobial and anti-inflammatory candidate as a pharmaceutic agent.

• 出版日期2015-7-31